Slavica Krantic

3.4k total citations · 1 hit paper
81 papers, 2.7k citations indexed

About

Slavica Krantic is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Slavica Krantic has authored 81 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 28 papers in Cellular and Molecular Neuroscience and 22 papers in Physiology. Recurrent topics in Slavica Krantic's work include Alzheimer's disease research and treatments (22 papers), Neuroscience and Neuropharmacology Research (18 papers) and Neuroinflammation and Neurodegeneration Mechanisms (16 papers). Slavica Krantic is often cited by papers focused on Alzheimer's disease research and treatments (22 papers), Neuroscience and Neuropharmacology Research (18 papers) and Neuroinflammation and Neurodegeneration Mechanisms (16 papers). Slavica Krantic collaborates with scholars based in France, Canada and China. Slavica Krantic's co-authors include Rémi Quirion, Naguib Mechawar, Stéphanie Reix, Chelsea Cavanagh, Pièrre Guerrier, Jean‐Guy Chabot, Emmanuel Moyse, Joanna Fombonne, Santos A. Susín and Stéphane Bastianetto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Trends in Neurosciences.

In The Last Decade

Slavica Krantic

80 papers receiving 2.7k citations

Hit Papers

Microbiota in neuroinflammation and synaptic dysfunction:... 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Slavica Krantic France 30 1.1k 732 704 413 318 81 2.7k
Yoon Hee Chung South Korea 31 1.3k 1.2× 562 0.8× 918 1.3× 364 0.9× 221 0.7× 153 3.5k
Jan Mulder Sweden 35 1.6k 1.4× 739 1.0× 1.4k 2.0× 460 1.1× 145 0.5× 114 4.6k
Yasunobu Okuma Japan 35 1.8k 1.7× 896 1.2× 975 1.4× 674 1.6× 799 2.5× 135 4.5k
Harald Höger Austria 31 1.6k 1.5× 501 0.7× 1.2k 1.7× 312 0.8× 152 0.5× 124 3.4k
Peter A. Wilce Australia 34 1.5k 1.4× 385 0.5× 1.4k 2.0× 326 0.8× 216 0.7× 144 3.6k
Yoshitatsu Sei United States 31 1.4k 1.3× 315 0.4× 666 0.9× 478 1.2× 185 0.6× 78 3.0k
Vitali Matyash Germany 20 2.0k 1.8× 734 1.0× 1.0k 1.5× 1.1k 2.7× 231 0.7× 22 4.2k
Lasse K. Bak Denmark 32 1.5k 1.3× 797 1.1× 1.8k 2.5× 634 1.5× 307 1.0× 78 3.7k
Francesc X. Soriano Spain 25 2.5k 2.3× 935 1.3× 858 1.2× 373 0.9× 313 1.0× 41 3.6k
María‐Ángeles Arévalo Spain 36 1.1k 1.0× 512 0.7× 745 1.1× 621 1.5× 180 0.6× 96 3.7k

Countries citing papers authored by Slavica Krantic

Since Specialization
Citations

This map shows the geographic impact of Slavica Krantic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Slavica Krantic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Slavica Krantic more than expected).

Fields of papers citing papers by Slavica Krantic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Slavica Krantic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Slavica Krantic. The network helps show where Slavica Krantic may publish in the future.

Co-authorship network of co-authors of Slavica Krantic

This figure shows the co-authorship network connecting the top 25 collaborators of Slavica Krantic. A scholar is included among the top collaborators of Slavica Krantic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Slavica Krantic. Slavica Krantic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rangon, Claire-Marie, Slavica Krantic, Emmanuel Moyse, & Bertrand Fougère. (2020). The Vagal Autonomic Pathway of COVID-19 at the Crossroad of Alzheimer’s Disease and Aging: A Review of Knowledge. Journal of Alzheimer s Disease Reports. 4(1). 537–551. 31 indexed citations
3.
Mahar, Ian, Siddhartha Mondragón‐Rodríguez, Chelsea Cavanagh, et al.. (2017). Phenotypic Alterations in Hippocampal NPY- and PV-Expressing Interneurons in a Presymptomatic Transgenic Mouse Model of Alzheimer’s Disease. Frontiers in Aging Neuroscience. 8. 327–327. 55 indexed citations
4.
Reed, Brian, Francine Béhar‐Cohen, & Slavica Krantic. (2016). Seeing Early Signs of Alzheimer's Disease Through the Lens of the Eye. Current Alzheimer Research. 14(1). 6–17. 16 indexed citations
5.
Mahar, Ian, Maria Antonietta Davoli, Jean‐Guy Chabot, et al.. (2015). Regional and sub-regional differences in hippocampal GABAergic neuronal vulnerability in the TgCRND8 mouse model of Alzheimer's disease. Frontiers in Aging Neuroscience. 7. 30–30. 59 indexed citations
6.
Goutagny, Romain, Ning Gu, Chelsea Cavanagh, et al.. (2013). Alterations in hippocampal network oscillations and theta–gamma coupling arise before overproduction in a mouse model of Alzheimer's disease. European Journal of Neuroscience. 37(12). 1896–1902. 188 indexed citations
7.
Yu, Wenfeng, Naguib Mechawar, Slavica Krantic, & Rémi Quirion. (2011). α7 Nicotinic receptor activation reduces β‐amyloid‐induced apoptosis by inhibiting caspase‐independent death through phosphatidylinositol 3‐kinase signaling. Journal of Neurochemistry. 119(4). 848–858. 53 indexed citations
8.
Yu, Wenfeng, Naguib Mechawar, Slavica Krantic, & Rémi Quirion. (2010). Evidence for the Involvement of Apoptosis-Inducing Factor–Mediated Caspase-Independent Neuronal Death in Alzheimer Disease. American Journal Of Pathology. 176(5). 2209–2218. 48 indexed citations
9.
Laras, Younès, et al.. (2009). Potential Neuroprotective Drugs in Cerebral Ischemia: New Saturated and Polyunsaturated Lipids Coupled to Hydrophilic Moieties: Synthesis and Biological Activity. Journal of Medicinal Chemistry. 52(14). 4358–4369. 15 indexed citations
10.
Fombonne, Joanna, Céline Charrier, Isabelle Goddard, Emmanuel Moyse, & Slavica Krantic. (2007). Leptin-Mediated Decrease of Cyclin A2 and Increase of Cyclin D1 Expression: Relevance for the Control of Prepubertal Rat Leydig Cell Division and Differentiation. Endocrinology. 148(5). 2126–2137. 20 indexed citations
11.
Gubkina, Olena, et al.. (2007). AIF-Mediated Programmed Necrosis: A Highly Orchestrated Way to Die. Cell Cycle. 6(21). 2612–2619. 133 indexed citations
12.
Reix, Stéphanie, Naguib Mechawar, Santos A. Susín, Rémi Quirion, & Slavica Krantic. (2006). Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer's disease. Neurobiology of Aging. 28(3). 351–356. 30 indexed citations
13.
Moyse, Emmanuel, Š. Bauer, Céline Charrier, et al.. (2006). Neurogenesis and neural stem cells in the dorsal vagal complex of adult rat brain: New vistas about autonomic regulations—a review. Autonomic Neuroscience. 126-127. 50–58. 25 indexed citations
14.
Coronas, Valérie, Kadiombo Bantubungi, Joanna Fombonne, et al.. (2004). Dopamine D3 receptor stimulation promotes the proliferation of cells derived from the post‐natal subventricular zone. Journal of Neurochemistry. 91(6). 1292–1301. 75 indexed citations
15.
Fombonne, Joanna, Stéphanie Reix, Ramahefarizo Rasolonjanahary, et al.. (2004). Epidermal Growth Factor Triggers an Original, Caspase-independent Pituitary Cell Death with Heterogeneous Phenotype. Molecular Biology of the Cell. 15(11). 4938–4948. 35 indexed citations
16.
Goddard, Isabelle, Š. Bauer, Alain Gougeon, et al.. (2001). Somatostatin Inhibits Stem Cell Factor Messenger RNA Expression by Sertoli Cells and Stem Cell Factor-Induced DNA Synthesis in Isolated Seminiferous Tubules1. Biology of Reproduction. 65(6). 1732–1742. 24 indexed citations
17.
Enjalbert, A, et al.. (2000). Somatostatin analog SMS 201995 inhibits proliferation in human leukemia T-cell line: Relevance of the adenylyl cyclase stimulation. Journal of Cellular Biochemistry. 78(4). 666–673. 15 indexed citations
18.
Bouras, Marwan, et al.. (2000). Evidence for a selective loss of somatostatin receptor subtype expression in male germ cell tumors of seminoma type. Carcinogenesis. 21(4). 805–810. 16 indexed citations
19.
Rabourdin‐Combe, Chantal, et al.. (1999). sst5 somatostatin receptor mRNA induction by mitogenic activation of human T-lymphocytes. Peptides. 20(3). 305–311. 21 indexed citations
20.
Krantic, Slavica, François Dubé, & Pièrre Guerrier. (1993). Evidence for a New Subtype of Serotonin Receptor in Oocytes of the Surf Clam Spisula solidissima. General and Comparative Endocrinology. 90(1). 125–131. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026